Back to search

Article

Antiviral Therapy Inhibited HBV-reactivation and Improved Long-term Outcomes in Patients Who Underwent Radiofrequency Ablation for HBV-related Hepatocellular Carcinoma

2022-10-26

Abstract excerpt

<h4>Background: </h4> The study aimed to examine the impact of antiviral therapy (AVT) on hepatitis B virus (HBV) reactivation and long-term outcomes after percutaneous radiofrequency ablation (PRFA) for HBV-related hepatocellular carcinoma (HCC). <h4>Methods: </h4>: Data on 538 consecutive patients who underwent PRFA for early-stage HBV-related HCC between 2009 and 2013 were reviewed. Propensity score matching (...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2f337e6a-5d9b-588f-964e-387f790eaf87
DOI
10.21203/rs.3.rs-2145210/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Antiviral Therapy Inhibited HBV-reactivation and Improved Long-term Outcomes in Patients Who Underwent Radiofrequency Ablation for HBV-related Hepatocellular CarcinomaDOI 10.21203/rs.3.rs-2145210/v1
Select a neighboring publication to make it the new centre.